Search results
Opinion | Closing Gender-Based Disease Disparities Starts in the Lab
MedPage Today· 5 days agoDespite the fact men have lower life expectancy than women and are at a higher risk of developing...
Luxa Biotechnology Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W...
Benzinga· 23 hours agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine
Newswise· 6 days agoBACKGROUNDStem cells are undifferentiated cells that possess the potential for self-renewal with the capacity to differentiate into multiple lineages. In humans
Type 1 Diabetes Market Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading...
Digital Journal· 6 days agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $64.17 Average PT from Brokerages
ETF DAILY NEWS· 1 day agoShares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have been given an average recommendation of “Buy” by the eight brokerages that are currently covering the company, MarketBeat ...